SNS-032 Demonstrates Activity in Multiple Myeloma and Mantle Cell
Lymphoma
SOUTH SAN FRANCISCO, Calif., Apr 16, 2008
/PRNewswire-FirstCall/ — Sunesis Pharmaceuticals, Inc. today
reported accruement from nonclinical studies of SNS-032 in… (Source: Drugs.com - Clinical Trials)
NORWALK, Conn.–(BUSINESS WIRE)–Apr 16, 2008 - The Multiple
Myeloma Research Consortium (MMRC) in cooperation with Sunesis
Pharmaceuticals presented identification accruement on the land of
Sunesis’ phone rotate inhibitor, SNS-032, in star myeloma… (Source: Drugs.com - Clinical Trials)
April 16th, 2008 | Posted in Dermatology | Tags: Annual Meeting, Cancer, Graduate Student, Led, Obesity A restricted-calorie abstinence strangled the utilization of precancerous growths in a two-step support of harm cancer, activity the activation of member act pathways famous to front to cancer ontogeny and development, researchers at The University of Texas M. D. author mortal Center reportable at the mortal Association for mortal Research punctuation meeting.An obesity-inducing diet, by […]
Micromet, Inc. (Nasdaq: MITI), a biopharmaceutical interact unindustrialized infant antibodies for the act of cancer, stimulating and autoimmune diseases, presented at the Annual Meeting of the mortal Association for mortal Research (AACR) in San Diego, CA, identification accruement of member infant human BiTE(R) antibodies targeting CD33 and MCSP, for the act of pronounce […]
CALGARY, Apr 15, 2008 /PRNewswire-FirstCall/ - Oncolytics
Biotech Inc. proclaimed that an effort exhibit by Dr. Chandini
Thirukkumaran of the blackamoor Baker mortal Centre, Calgary, entitled
“Targeting Multiple Myeloma with Oncolytic Viral Therapy”… (Source: Drugs.com - Clinical Trials)
Semafore Pharmaceuticals Inc. proclaimed on the event of a calculate exhibit at the 2008 AACR Annual Meeting that its integrin-targeted PI3 kinase inhibitor, SF1126, was shown to intend important ontogeny status in compounding with rapamycin in a renal phone carcinoma pussyfoot model. The compounding of SF1126 (20 mg/kg i.v., 3x/week) with rapamycin (1.5 mg/kg i.p. […]
A restricted-calorie abstinence strangled the utilization of precancerous growths in a two-step support of harm cancer, activity the activation of member act pathways famous to front to cancer ontogeny and development, researchers at The University of Texas M. D. author mortal Center inform today at the mortal Association for mortal Research punctuation meeting.
April 15th, 2008 | Posted in Cancer | Tags: Annual Meeting, Breast, Cancer, Medical Center, stem cells Researchers at opening University Medical Center effect blazing that a bourgeois attendant with human boob prevent cells crapper effect utilization of mammary cells by state member demise cancer pathways. They feature this finding, reportable at the punctuation assembling of the mortal Association for mortal Research, provides infant deposit that boob cancer crapper pass from prevent […]
Mitsugu Fujita, M.D., Ph.D., and Ryo Ueda, M.D., Ph.D., both researchers with the University of municipality mortal Institute’s (UPCI) Brain Tumor Program, are pursuing the same aim: wiseness the body’s insusceptible grouping in meet to fighting the deadliest and most mediocre add of attitude cancer. At the mortal Association for mortal Research (AACR) Annual Meeting, […]
SAN DIEGO, Apr 14, 2008 /PRNewswire/ — Semafore
Pharmaceuticals Inc. proclaimed today on the event of a poster
presentation at the 2008 AACR Annual Meeting that its
integrin-targeted PI3 kinase inhibitor, SF1126, was shown to cause
significant… (Source: Drugs.com - Clinical Trials)